Taylor Chartier Email & Phone Number
@modicusprime.com
LinkedIn matched
Who is Taylor Chartier? Overview
A concise factual answer block for searchers comparing this professional profile.
Taylor Chartier is listed as CEO at Modicus Prime | AI for Drug Production and Patient Health at Modicus Prime, a company with 2 employees, based in Austin, Texas Metropolitan Area, United States. AeroLeads shows a work email signal at modicusprime.com and a matched LinkedIn profile for Taylor Chartier.
Taylor Chartier previously worked as Chief Executive Officer at Modicus Prime and Venture Analyst at Valley Capital Partners. Taylor Chartier holds Master Of Science (Ms), Chemical Engineering from University Of Rochester.
Email format at Modicus Prime
This section adds company-level context without repeating Taylor Chartier's masked contact details.
AeroLeads found 1 current-domain work email signal for Taylor Chartier. Compare company email patterns before reaching out.
About Taylor Chartier
Taylor Chartier is a former data scientist and engineer from the pharmaceutical industry. She has supported FDA Biologics License Applications by advancing Quality by Design initiatives in Process Development, Manufacturing Sciences and Technology, and Commercial Manufacturing operations. She has also applied machine learning and artificial intelligence for multivariate modeling to optimize pharmaceutical production and perform root cause analysis, most recently at Bayer Pharmaceuticals. Her education consists of a 5-year accelerated bachelors and masters program in chemical engineering at the University of Rochester, NY, and she was most recently pursuing a PhD in applied AI with wearables research for Parkinson’s patients at the University of Luxembourg. During her time supporting various technical initiatives in pharma, she became very familiar with the challenges the sector faces to maintain product quality. It was in this capacity that she recognized the significant potential for AI in process development and commercial drug manufacturing. So Chartier started the AI software company, Modicus Prime, to provide pharma with the right AI computational techniques and apply them in a vigorous way to help safely and more efficiently produce drugs for patients. Modicus Prime’s computer vision software automates biologics image analysis and is designed to solve for the cost, legal, and waste liabilities from product quality failures across R&D and manufacturing. Modicus Prime is venture-backed and has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), eLabNext (Eppendorf), Dotmatics, PlugandPlay Health, and Techstars. Modicus Prime is also a resident of Johnson&Johnson JLABS at the Texas Medical Center. The company’s proprietary GxP-compliant software, mpVision, enables scientists to independently train their own AI to achieve real-time classification of any imaging data – from biologic morphology analysis to commercial contamination detection – for comprehensive quality control across R&D and manufacturing. mpVision has been globally tested by scientists at a Top 10 Pharma, and its features are mapped to the unmet needs of the pharmaceutical industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs.
Taylor Chartier's current company
Company context helps verify the profile and gives searchers a useful next step.
Taylor Chartier work experience
A career timeline built from the work history available for this profile.
Venture Analyst
Current
Senior Engineer, Process Analysis And Optimization
- Developing machine learning tools, probabilistic methods, and multivariate modeling strategies (e.g. Monte Carlo, PLS, OPLS, OPLS-DA, and hierarchical modeling) to enhance commercial cell culture and purification.
- Automating commercial data extraction from OSIsoft Time Series Database, data preprocessing, and multivariate model testing.
- Deployed a cell culture monitoring model with KNIME Server, which provides model outputs to company stakeholders.
- Leveraging neural networks with a ResNet fast.ai architecture to extract mass transfer and isotherm parameters from purification chromatograms.
Digital Innovation Consultant
- Selected into global team to explore medication adherence technologies; introduced team to computer vision applications.
Emerald Cloud Lab
- Utilized Mathematica to navigate through experimental and inventory data in git repositories.
- Operated software systems with respective instruments, which included automated liquid-handling Hamilton workstations.
- Performed chemical experiments according to both in-house research and customer requests, including mass spectrometry, lyophilization, HPLC, fluorescence kinetics, absorbance quantification, sample manipulations, and.
Development Engineer, Manufacturing Sciences And Technology (Ms&T)
- Implemented DOE methods to develop and statistically support commercial drug characterization studies and BLA filing initiatives.
- Utilized JMP software to both screen and model key performance parameters of batch reactor growth and production phases. Received certificates for JMP training in Design of Experiment and ANOVA/Regression analysis.
- Applied principal component analysis (PCA) on serum constituents to characterize raw material.
- Supported upstream QbD strategy by quantitatively classifying cell culture critical performance parameters with JMP modeling. Introduced Multivariate Acceptable Range (MAR) approach to upstream characterization efforts.
- Developed linear upstream scale down model by evaluating drug substance and performance attributes.
- Statistically evaluated historical trends, commercial data, and laboratory scale data to support product life cycle management.
Materials Interface Intern, Contamination Group
- Conducted ex-situ test stand infusions to screen extracts with organic and ionic contaminants produced by fuel cell materials for adverse effects on electrode, membrane, and membrane electrode assembly (MEA) fuel cell.
- Performed in-situ cyclic voltammetry experiments on leachant solutions to evaluate varying degrees of electrochemical surface area depletion and voltage recovery of Pt/V electrodes. Parasitic current Invention Method.
Research And Development Intern, Biologics New And Enabling Technologies
- Assisted department integrating novel technology into bulk, fine, and formulation stages of monoclonal antibody purification platform to optimize product stream purity while also conducting CHO bioreactor procedures to.
- Recommended single-use tangential flow filtration techniques for bioprocessing streams by conducting feed diafiltrations and concentrations to compare single-use membrane flux, permeability, and recovery performances.
- Independently validated integration of Pall’s novel Single-Pass Tangential Flow Filtration System into Merck’s purification platform by increasing purity, truncating residence time, and minimizing product loss in.
Biofuel Research Assistant, Dept Of Chemical Engineering
- Bioenergy laboratory formulating new strategies for efficient hydrogen and ethanol production of bacterium C. thermocellum.
- Elucidated DNA-binding properties of potential transcription factors through protein induction and purification techniques.
- Utilized BIO-RAD Experion, LightShift Chemiluminescent EMSA Kits, RoboCycler PCR, Thermo Scientific Spectrophotometer, and NanoScope Atomic Force Microscope (AFM) to characterize DNA-protein interactions in C..
Laboratory Technician, Magnetorheological Finishing (Mrf) Laboratory
- Member of intradepartmental team that developed methods for coating corrosive-resistant carbonyl iron particles with zirconia.
- Operated Colloidal Dynamics AcoustoSizer II, Brookfield Rheometer, and Brookhaven ZetaPALS to measure particle size, zeta potential, and dielectric constants of zirconia-coated carbonyl iron particles while refining a.
Colleagues at Modicus Prime
Other employees you can reach at modicusprime.com. View company contacts for 2 employees →
Diana Makovetska
Colleague at Modicus PrimeLviv, Lviv, Ukraine, Ukraine
View →
DV
David Vardanyan
Colleague at Modicus PrimeAustin, Texas Metropolitan Area, United States
View →
GK
Gavin Karr
Colleague at Modicus PrimeDurham, North Carolina, United States, United States
View →
AG
Arsen Gevorgyan
Colleague at Modicus PrimeArmenia, Armenia
View →
Taylor Chartier education
Master Of Science (Ms), Chemical Engineering
Doctor Of Philosophy - Phd, Artifical Intelligence Applications In Systems Biomedicine
Frequently asked questions about Taylor Chartier
Quick answers generated from the profile data available on this page.
What company does Taylor Chartier work for?
Taylor Chartier works for Modicus Prime.
What is Taylor Chartier's role at Modicus Prime?
Taylor Chartier is listed as CEO at Modicus Prime | AI for Drug Production and Patient Health at Modicus Prime.
What is Taylor Chartier's email address?
AeroLeads has found 1 work email signal at @modicusprime.com for Taylor Chartier at Modicus Prime.
Where is Taylor Chartier based?
Taylor Chartier is based in Austin, Texas Metropolitan Area, United States while working with Modicus Prime.
What companies has Taylor Chartier worked for?
Taylor Chartier has worked for Modicus Prime, Valley Capital Partners, Bayer, Emerald Therapeutics, and Shire Pharmaceuticals.
Who are Taylor Chartier's colleagues at Modicus Prime?
Taylor Chartier's colleagues at Modicus Prime include Diana Makovetska, David Vardanyan, Gavin Karr, and Arsen Gevorgyan.
How can I contact Taylor Chartier?
You can use AeroLeads to view verified contact signals for Taylor Chartier at Modicus Prime, including work email, phone, and LinkedIn data when available.
What schools did Taylor Chartier attend?
Taylor Chartier holds Master Of Science (Ms), Chemical Engineering from University Of Rochester.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialCheck these profiles if this is not the Taylor Chartier you were looking for.
View similar profiles